← Leaderboards
Swagata Kar
Bioqual, Inc.
$1,080,129
Attributed
$1,080,129
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $983.3K · FY2018–19$1M$750K$500K$250K$0
'18
'19
Funding mix
By agency
NIH$1,080,129 · 1
By mechanism
N01$1,080,129 · 1
Top collaborators
No co-investigators on record.
Most similar at Bioqual, Inc.
Same institution · by research overlap
- Hanne Elyard$5,288,850
- Mark Lewis$23,081,773
- Hanne Andersen$3,809,803
- Dorothy Patton$2,329,869
- Thomas Patterson$23,105
Others in their field
Other Emerging Leaders on “Animal Model”
- Ted Ross · University Of Georgia$71,962,304
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,644,409
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Gary Fanger · Rise Therapeutics, Llc$16,982,327
Research focus
Animal ModelContractsInfectious Disease ModelStandardizationEfficacy TestingAnimal Model DevelopmentLicensureImmunogenicityNanoparticleSalmonella ParatyphiSalmonella VaccinesUniversal Influenza VaccineVaccination StrategyVaccinesVibrio CholeraeAttenuatedCholera VaccineConjugate VaccinesEvaluationFerretsInfluenza VaccinationInfluenzavirus
Grant awards (3)
Task A27: Immunogenicity Study of a Live Attenuated Vibrio Cholerae Vaccine in Mice$96,873
N01 · FY2019 · AI · contact PI
Task A23: Ferret Models for the Evaluation of Universal Influenza Vaccines and Vaccination Strategies$858,192
N01 · FY2018 · AI · contact PI
Task A26: Immunogenicity Studies of a nanoparticle conjugate vaccine against Salmonella paratyphi A in Mice$125,064
N01 · FY2018 · AI · contact PI